Assessment and grading of mucosal inflammation in colonic diverticular disease

Journal of Clinical Gastroenterology

Volumn 42, Issue 6, 2008, Pages 699-703

  Tursi, Antonio ^a   Brandimarte, Giovanni ^a   Elisei, Walter ^b   Giorgetti, Gian Marco ^c   Inchingolo, Cosimo Damiano ^d   Danese, Silvio ^d   Aiello, Fabio ^d  

^a Lorenzo Bonomo Hospital   (Italy)

^b Cristo Re Hospital   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL DENSITY; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLITIS; COLON DIVERTICULOSIS; DISEASE SEVERITY; DIVERTICULOSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; AGED; CASE CONTROL STUDY; CELL COUNT; CLASSIFICATION; COLONOSCOPY; HOSPITALIZATION; INTESTINE MUCOSA; LYMPHOCYTE; METABOLISM; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

AGED; CASE-CONTROL STUDIES; CELL COUNT; COLONOSCOPY; DIVERTICULITIS, COLONIC; DIVERTICULOSIS, COLONIC; FEMALE; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; SEVERITY OF ILLNESS INDEX;

EID: 54649083282     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3180653ca2     Document Type: Article

References (16)

1. Floch MH, Bina I. The natural history of diverticulitis: fact and theory. J Clin Gastroenterol. 2004;38(suppl 5):2-7.
2. Tursi A. Acute diverticulitis of the colon - current medical therapeutic management. Exp Opin Pharmacother. 2004;5:145-149.
3. Kolher L, Souerland S, Neugebauer E; for the Scientific Committee of the European Association for Endoscopic Surgery (EAES). Results of a consensus development conference. Diagnosis and treatment of diverticular disease. Surg Endosc. 1999;13:430-436.
4. Pereira JM, Sirlin CB, Pinto PS, et al. Disproportionate fat stranding: a helpful ct sign in patients with acute abdominal pain. RadioGraphics. 2004;24:703-715.
5. Tursi A. Mesalazine for diverticular disease of the colon - a new role for an old drug. Expert Opin Pharmacother. 2005;6:69-74.
6. Di Mario F, Aragona G, Leandro G, et al. Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci. 2005; 50:581-586.
7. Tursi A, Brandimarte G, Giorgetti GM, et al. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomised, open-label study. J Clin Gastroenterol. 2006;40: 312-316.
8. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg. 1998;22:382-389.
9. Izzo AA, Mascolo N, Capasso F. Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci. 1998;43: 1605-1620.
10. Dugas B, Mercenier A, Lenoir-Wijnkoop I, et al. Immunity and probiotics. Immunol Today. 1999;20:387-390.
11. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998;42:2-7.
12. Borruel N, Casellas F, Antolin M, et al. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol. 2003;98:865-870.
13. Floch MH, Fuchs H-M. Modification of stool content by increased bran intake. J Clin Nutr. 1978;31 (Suppl):185-189.
14. Isolauri E, Sütas Y, Kankaapää P, et al. Probiotics: effect on immunity. Am J Clin Nutr. 2001;73(suppl):444-450.
15. Narayan R, Floch MH. Microscopic colitis as part of the natural history of diverticular disease (abstract). Am J Gastroenterol. 2002; 97(suppl):112.
16. Morini S, Hassan C, Zullo A, et al. Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case-control study. Aliment Pharmacol Ther. 2005;21:1385-1390.